Cutaneous complications of hormonal replacement therapy.
Mor
Z
Z
Department of Obstetrics and Gynecology, Assaf Harofe Medical Center, Zerifin, Israel.
Caspi
E
E
D000279:Administration, Cutaneous; D001327:Autoimmune Diseases / Q000209:etiology; D003875:Drug Eruptions / Q000209:etiology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008545:Melanoma / Q000139:chemically induced; D010859:Pigmentation Disorders / Q000139:chemically induced; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced; D011374:Progesterone / Q000009:adverse effects; D011960:Receptors, Estrogen / Q000187:drug effects; D012307:Risk Factors; D012867:Skin / Q000187:drug effects; D012871:Skin Diseases / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000139:chemically induced
D004967:Estrogens; D011960:Receptors, Estrogen; D011374:Progesterone